Table 2 Number of patients with each co-morbidity by quartile of HHL (arm span − body height).

From: Implications of historical height loss for prevalent vertebral fracture, spinal osteoarthritis, and gastroesophageal reflux disease

 

Quartile 1

Quartile 2

Quartile 3

Quartile 4

P-value

Prevalent vertebral fracture, No. (%)

27 (11.5)

36 (15.3)

70 (29.7)

132 (56.2)

 < 0.001

Spinal osteoarthritis, No. (%)

105 (44.7)

139 (58.9)

165 (69.9)

205 (87.2)

 < 0.001

Diabetes mellitus, No. (%)

33 (14.0)

45 (19.1)

30 (12.7)

26 (11.1)

0.08

Dyslipidemia, No. (%)

125 (53.2)

128 (54.2)

108 (45.8)

100 (42.6)

0.03

Hypertension, No. (%)

99 (42.1)

115 (48.7)

144 (61.0)

172 (73.2)

 < 0.001

Vascular events, No. (%)

16 (6.8)

30 (12.7)

39 (16.5)

53 (22.6)

 < 0.001

GERD, No. (%)

9 (3.8)

13 (5.5)

22 (9.3)

36 (15.3)

 < 0.001

  1. Quartile 1 ranged from − 12.5 to − 0.2 cm (n = 235).
  2. Quartile 2 ranged from − 0.1 to 3.7 cm (n = 236).
  3. Quartile 3 ranged from 3.8 to 7.6 cm (n = 236).
  4. Quartile 4 ranged from 7.7 to 24.0 cm (n = 235).
  5. HHL, historical height loss; GERD, gastroesophageal reflux disease.
Back to article page